Skip to main content

Table 6 Release criteria for MyDerm®

From: Quality management overview for the production of a tissue-engineered human skin substitute in Malaysia

Test

Specification

Physical characteristics

Viability

 ≥ 70%

Total number of keratinocyte passages

 ≤ 6

Keratinocyte cell count

up to 2 × 107 (depending on size)

Total number of fibroblast passages

 ≤ 6

Fibroblast cell count

up to 2 × 107 (depending on size)

Product released

 ≤ 72 h from end of manufacture

Sterility testing

Micro-contamination testing

Not Detected

Mycoplasma testing

Not Detected

Endotoxin testing

 < 0.25 EU/ml

Gram stain

No organisms detected